English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The treatment of the malignant diseases requires the use of combination chemotherapy in multiple cycles administered to achieve adequate tumor cell kill without lifethreatening toxicity or the development of tumor cell resistance. Patients and methods:72 patients (48 women and 24 men, median age – 47, from 24 to 71years with urinary tract infections (UTI), hospitalized in the Clinic of Hematology for the period January 2006-May 2008. Urinalysis: microscopic examination – white blood cells (WBC), bacteria; urine culture; sensitivities of culture. Blood tests: urea (kinetic UV test ), creatinin (Jaffe kinetic), CRP (immunoturbidimetric method), blood culture, sensitivities of culture. Results and conclusions:The urinary tract infections are a common complication during the combination chemotherapy patients with hematological malignancies. For the period 2006-2008, 72 patients undergoing combination chemotherapy were diagnosed with UTI.

Infections in urinary tract of patients with haematological malignancies undergoing antineoplastic therapy